DLBCL arising from indolent lymphomas: How are they different?

Erin M Parry1, Sandrine Roulland2, Jessica Okosun3

  • 1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA; Harvard Medical School, Boston, MA; Broad Institute of MIT and Harvard, Cambridge, MA.

Seminars in Hematology
|December 10, 2023
PubMed
Summary

Transformation to diffuse large B-cell lymphoma (DLBCL) is an unpredictable event in indolent lymphomas. This review covers the clinical and biological aspects of transformed lymphomas, highlighting genetic basis and outcomes.